regulatory
confidence high
sentiment negative
materiality 0.50
Sanara, MiMedx hit with FTC Second Request; HSR waiting period for merger extended
Sanara MedTech Inc.
- FTC issued a Second Request for additional information and documentary materials to Sanara MedTech and MiMedx on October 15, 2026, extending the HSR Act waiting period.
- Waiting period now runs 30 days after substantial compliance with the Second Request, unless extended voluntarily by the parties or terminated earlier by the FTC.
- Under the Merger Agreement, MiMedx's Mustang Merger Sub, Inc. merges into Sanara, with Sanara surviving as a wholly-owned subsidiary of MiMedx.
- Closing still conditioned on HSR waiting period expiration or termination plus other Merger Agreement conditions; Sanara says it continues to work constructively with the FTC.
- MiMedx filed a Form S-4 registration statement including Sanara's proxy/prospectus, which has been mailed to Sanara stockholders; 8-K signed by CFO Elizabeth Taylor on Oct 16, 2026.